Low-dose atropine is a safe, non-invasive eye drop treatment that helps slow the progression of myopia (nearsightedness) in children. By relaxing the focusing muscles of the eye, atropine reduces the eye’s tendency to elongate, one of the leading causes of worsening myopia. At low doses, atropine has minimal impact on daily vision but provides powerful long-term benefits for eye health.
Atropine works by relaxing the ciliary muscle, which controls how the eye focuses. This reduces strain and slows the eye's elongation. Studies show that children using low-dose atropine (typically 0.05%) experience 30–50% slower progression of myopia over time, significantly lowering their risk of developing high myopia and related eye conditions like glaucoma, retinal detachment, and cataracts.
Low-dose atropine is ideal for...
We’ll assess your child’s vision and eye health to determine the best approach.
Yes! Low-dose atropine is well-tolerated and safe for long-term use. Although it is FDA-approved, the low-dose formulation is used off-label and must be ordered through a compounding pharmacy.
Possible side effects may include...
We monitor all patients closely and adjust treatment if needed to ensure comfort and effectiveness.
Year 1: Initial Management
Year 2 & Beyond: Maintenance
Low-dose atropine is applied as one drop per eye, nightly. Consistency is key to slowing progression effectively. We’ll guide you through administration and provide tips for building a smooth bedtime routine.
While results take time, most patients show measurable slowing of myopia progression within a few months. Regular follow-ups help track effectiveness and make any necessary adjustments.
Yes! Atropine can be safely combined with:
A combination approach can enhance overall effectiveness, and we’ll help you build the best plan for your child.
If atropine use is stopped, the protective effects may wear off, and myopia may begin to progress again. We’ll work with you to decide when it’s appropriate to taper or discontinue use, and offer alternatives if needed.
Fighting Myopia
Copyright © 2025 Fighting Myopia - All Rights Reserved.